Oxcarbazepine add-on for drug-resistant partial epilepsy
نویسندگان
چکیده
منابع مشابه
Tiagabine add-on for drug-resistant partial epilepsy.
BACKGROUND Epilepsy is a common neurological condition that affects almost 0.5% to 1% of the population. Nearly 30% of people with epilepsy are resistant to currently available drugs. Tiagabine is one of the newer antiepileptic drugs; its effects as an adjunct (add-on) to standard drugs are assessed in this review. OBJECTIVES To evaluate the effects of add-on treatment with tiagabine on seizu...
متن کاملLAMOTRIGINE AS ADD-ON THERAPY IN CHILDREN WITH DRUG-RESISTANT EPILEPSY (IRANIAN EXPERIENCE)
Lamotrigine (LTG), a newly developed antiepileptic drug (AED), is efficacious in treating refractory epilepsy. This study was designed to evaluate the efficacy and safety of LTG as add-on therapy in 40 children with refractory epilepsy. The trial was an open-labeled prospective study in children with drug-resistant epilepsy aged
متن کاملlamotrigine as add-on therapy in children with drug-resistant epilepsy (iranian experience)
lamotrigine (ltg), a newly developed antiepileptic drug (aed), is efficacious in treating refractory epilepsy. this study was designed to evaluate the efficacy and safety of ltg as add-on therapy in 40 children with refractory epilepsy. the trial was an open-labeled prospective study in children with drug-resistant epilepsy aged <14 years, who had at least 4 seizures per month in spite of recei...
متن کاملLong-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy
Vigabatrin (VGB) has been shown in a number of clinical trials with varying designs to be effective and well-tolerated as both add-on therapy and monotherapy in epilepsy with partial seizures with or without secondary generalization as well as in infantile spasms. The present study is an open, long-term (1 year) extension of a randomized double-blind placebo-controlled multicentre Canadian tria...
متن کاملOne-year Observation of Topiramate in Add-on Therapy in Patients with Drug Resistant Epilepsy
Introduction. Topiramate (Topamax, TPM) is an effective AED, used to treat simple partial, complex partial and secondary generalised to tonic sei zures. The drug's pharmakokinetic profile and the outcomes of clinical trials suggest that TPM may be used in both polytherapy and monotherapy. Objective. The aim of the study was to conduct a one-year observation of the effectiveness and safety of to...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2016
ISSN: 1465-1858
DOI: 10.1002/14651858.cd002028.pub2